Galmed Pharmaceuticals Ltd.

GLMD
Date Form Type SEC Filings
Oct 28, 2024 EFFECT Profile Financial Statements
Oct 28, 2024 424B3 Profile Financial Statements
Oct 21, 2024 F-1 Profile Financial Statements
Oct 21, 2024 6-K Profile Financial Statements
Oct 15, 2024 6-K Profile Financial Statements
Sep 25, 2024 6-K Profile Financial Statements
Sep 20, 2024 SC 13G/A Profile Financial Statements
Sep 20, 2024 SC 13G Profile Financial Statements
Sep 20, 2024 6-K Profile Financial Statements
Sep 19, 2024 6-K Profile Financial Statements
Sep 16, 2024 6-K Profile Financial Statements
Sep 9, 2024 EFFECT Profile Financial Statements
Sep 9, 2024 424B3 Profile Financial Statements
Aug 30, 2024 F-1 Profile Financial Statements
Aug 30, 2024 6-K Profile Financial Statements
Jul 18, 2024 6-K Profile Financial Statements
Jul 11, 2024 6-K Profile Financial Statements
Apr 4, 2024 20-F Profile Financial Statements
Nov 29, 2023 EFFECT Profile Financial Statements
Nov 22, 2023 POS AM Profile Financial Statements
Nov 22, 2023 6-K Profile Financial Statements
Nov 20, 2023 6-K Profile Financial Statements
Sep 26, 2023 6-K Profile Financial Statements
Sep 22, 2023 6-K Profile Financial Statements
Sep 21, 2023 6-K/A Profile Financial Statements
Sep 20, 2023 6-K Profile Financial Statements
Sep 13, 2023 6-K Profile Financial Statements
Aug 9, 2023 6-K Profile Financial Statements
Jul 21, 2023 SC 13G Profile Financial Statements
Jul 18, 2023 6-K Profile Financial Statements
Jul 18, 2023 424B4 Profile Financial Statements
Jul 14, 2023 6-K Profile Financial Statements
Jul 14, 2023 EFFECT Profile Financial Statements
Jul 13, 2023 F-1/A Profile Financial Statements
Jul 12, 2023 F-1/A Profile Financial Statements
Jul 10, 2023 6-K Profile Financial Statements
Jun 28, 2023 FWP Profile Financial Statements
Jun 28, 2023 F-1/A Profile Financial Statements
Jun 1, 2023 6-K Profile Financial Statements